These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 20967208)

  • 1. Specific variants in the MLH1 gene region may drive DNA methylation, loss of protein expression, and MSI-H colorectal cancer.
    Mrkonjic M; Roslin NM; Greenwood CM; Raptis S; Pollett A; Laird PW; Pethe VV; Chiang T; Daftary D; Dicks E; Thibodeau SN; Gallinger S; Parfrey PS; Younghusband HB; Potter JD; Hudson TJ; McLaughlin JR; Green RC; Zanke BW; Newcomb PA; Paterson AD; Bapat B
    PLoS One; 2010 Oct; 5(10):e13314. PubMed ID: 20967208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR.
    Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W
    Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haplotype defined by the MLH1-93G/A polymorphism is associated with MLH1 promoter hypermethylation in sporadic colorectal cancers.
    Miyakura Y; Tahara M; Lefor AT; Yasuda Y; Sugano K
    BMC Res Notes; 2014 Nov; 7():835. PubMed ID: 25421847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsatellite instability, MLH1 promoter methylation, and BRAF mutation analysis in sporadic colorectal cancers of different ethnic groups in Israel.
    Vilkin A; Niv Y; Nagasaka T; Morgenstern S; Levi Z; Fireman Z; Fuerst F; Goel A; Boland CR
    Cancer; 2009 Feb; 115(4):760-9. PubMed ID: 19127559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of somatic mutl homolog 1 promoter hypermethylation in Lynch syndrome colorectal cancer.
    Moreira L; Muñoz J; Cuatrecasas M; Quintanilla I; Leoz ML; Carballal S; Ocaña T; López-Cerón M; Pellise M; Castellví-Bel S; Jover R; Andreu M; Carracedo A; Xicola RM; Llor X; Boland CR; Goel A; Castells A; Balaguer F;
    Cancer; 2015 May; 121(9):1395-404. PubMed ID: 25557234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dynamic DNA methylation landscape of the
    Savio AJ; Mrkonjic M; Lemire M; Gallinger S; Knight JA; Bapat B
    Clin Epigenetics; 2017; 9():26. PubMed ID: 28293327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.
    Lawes DA; Pearson T; Sengupta S; Boulos PB
    Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MLH1 -93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer.
    Raptis S; Mrkonjic M; Green RC; Pethe VV; Monga N; Chan YM; Daftary D; Dicks E; Younghusband BH; Parfrey PS; Gallinger SS; McLaughlin JR; Knight JA; Bapat B
    J Natl Cancer Inst; 2007 Mar; 99(6):463-74. PubMed ID: 17374836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MLH1-93G > A is a risk factor for MSI colorectal cancer.
    Whiffin N; Broderick P; Lubbe SJ; Pittman AM; Penegar S; Chandler I; Houlston RS
    Carcinogenesis; 2011 Aug; 32(8):1157-61. PubMed ID: 21565826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite-stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter.
    Yearsley M; Hampel H; Lehman A; Nakagawa H; de la Chapelle A; Frankel WL
    Hum Pathol; 2006 Jul; 37(7):831-8. PubMed ID: 16784982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening.
    Poynter JN; Siegmund KD; Weisenberger DJ; Long TI; Thibodeau SN; Lindor N; Young J; Jenkins MA; Hopper JL; Baron JA; Buchanan D; Casey G; Levine AJ; Le Marchand L; Gallinger S; Bapat B; Potter JD; Newcomb PA; Haile RW; Laird PW;
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3208-15. PubMed ID: 18990764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MLH1 region polymorphisms show a significant association with CpG island shore methylation in a large cohort of healthy individuals.
    Savio AJ; Lemire M; Mrkonjic M; Gallinger S; Zanke BW; Hudson TJ; Bapat B
    PLoS One; 2012; 7(12):e51531. PubMed ID: 23240038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanism of microsatellite instability is different in synchronous and metachronous colorectal cancer.
    Velayos FS; Lee SH; Qiu H; Dykes S; Yiu R; Terdiman JP; Garcia-Aguilar J
    J Gastrointest Surg; 2005 Mar; 9(3):329-35. PubMed ID: 15749592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification.
    Parsons MT; Buchanan DD; Thompson B; Young JP; Spurdle AB
    J Med Genet; 2012 Mar; 49(3):151-7. PubMed ID: 22368298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The polymorphic variant rs1800734 influences methylation acquisition and allele-specific TFAP4 binding in the MLH1 promoter leading to differential mRNA expression.
    Thomas R; Trapani D; Goodyer-Sait L; Tomkova M; Fernandez-Rozadilla C; Sahnane N; Woolley C; Davis H; Chegwidden L; Kriaucionis S; Maughan T; Leedham S; Palles C; Furlan D; Tomlinson I; Lewis A
    Sci Rep; 2019 Sep; 9(1):13463. PubMed ID: 31530880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The MLH1 polymorphism rs1800734 and risk of endometrial cancer with microsatellite instability.
    Russell H; Kedzierska K; Buchanan DD; Thomas R; Tham E; Mints M; Keränen A; Giles GG; Southey MC; Milne RL; Tomlinson I; Church D; Spurdle AB; O'Mara TA; Lewis A
    Clin Epigenetics; 2020 Jul; 12(1):102. PubMed ID: 32641106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MLH1 promoter methylation, diet, and lifestyle factors in mismatch repair deficient colorectal cancer patients from EPIC-Norfolk.
    Gay LJ; Arends MJ; Mitrou PN; Bowman R; Ibrahim AE; Happerfield L; Luben R; McTaggart A; Ball RY; Rodwell SA
    Nutr Cancer; 2011; 63(7):1000-10. PubMed ID: 21875327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of microsatellite instability, MLH1 expression and hMLH1 promoter hypermethylation in colorectal carcinomas among Tunisians patients.
    Kria Ben Mahmoud L; Arfaoui A; Khiari M; Chaar I; Lounis A; Sammoud S; Ben Hmida AM; Gharbi L; Mzabi SR; Bouraoui S
    Tunis Med; 2012; 90(8-9):646-53. PubMed ID: 22987381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MSI in endometrial carcinoma: absence of MLH1 promoter methylation is associated with increased familial risk for cancers.
    Whelan AJ; Babb S; Mutch DG; Rader J; Herzog TJ; Todd C; Ivanovich JL; Goodfellow PJ
    Int J Cancer; 2002 Jun; 99(5):697-704. PubMed ID: 12115503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer risks for the relatives of colorectal cancer cases with a methylated MLH1 promoter region: data from the Colorectal Cancer Family Registry.
    Levine AJ; Win AK; Buchanan DD; Jenkins MA; Baron JA; Young JP; Long TI; Weisenberger DJ; Laird PW; McCall RL; Duggan DJ; Haile RW
    Cancer Prev Res (Phila); 2012 Feb; 5(2):328-35. PubMed ID: 22144422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.